Design, Synthesis and in vivo Evaluation of Novel C-Aryl Glucosides as Potent Sodium-Dependent Glucose Cotransporters Inhibitors for the Treatment of Diabetes

Chemical Biology & Drug Design
Zheng LiHai Qian

Abstract

A series of novel C-aryl glucosides with substituents at the 3'-position or cyclization at 3', 4'-positions of the distal aryl ring were designed and synthesized, which might decrease the oxidative metabolism of dapagliflozin. Preliminary evaluation for hypoglycemic effect and the risk of hypoglycemia were carried out both in normal and in streptozotocin-induced diabetic mice. Among the synthesized compounds, compound 19a exerted potency-similarity with dapagliflozin and triggered the hypoglycemic effect in a dose-dependent manner. Besides, compound 19a, even at the high dose of 10 mg/kg, revealed a low risk of hypoglycemia. In further studies, 19a exhibited sustained antihyperglycemic effect without particular side-effects in 30-day chronic diabetic mice studies. Moreover, histological changes in the pancreas of diabetic mice indicated 19a might protect pancreatic β-cell from apoptosis by reducing the damage of glucotoxicity. All of these results demonstrated that compound 19a, with excellent in vivo pharmacological activity and safety profile, was considered to be a promising drug candidate for the treatment of diabetes mellitus.

References

Jan 3, 2001·American Journal of Physiology. Renal Physiology·E M Wright
Apr 5, 2007·Current Medical Research and Opinion·Claresa Levetan
Dec 10, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·M ObermeierW G Humphreys
Apr 15, 2010·JAMA : the Journal of the American Medical Association·Olivia J PhungCraig I Coleman
May 29, 2010·Nature Reviews. Drug Discovery·Edward C Chao, Robert R Henry
Jan 11, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wenbin ZhangYong-Xiang Wang
Mar 5, 2011·Kidney International. Supplement·James F List, Jean M Whaley
Mar 19, 2011·Journal of Medicinal Chemistry·Nicholas A Meanwell
Apr 30, 2011·Physiological Reviews·Ernest M WrightBruce A Hirayama
Nov 29, 2011·Journal of Molecular Modeling·Chunlei TangWenlong Huang
Dec 27, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Peter Mayer
Oct 10, 2013·Integrative Biology : Quantitative Biosciences From Nano to Macro·Edina C Wang, Andrew Z Wang
Sep 9, 2010·ACS Medicinal Chemistry Letters·Nobuyuki NegoroYu Momose

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis